ISDS Case Map
medicines
MSF staff and supporters rally outside the offices of the European Commission to deliver an open letter of protest against ongoing trade talks between the European Union and India that could damage access to affordable medicines.
How a trade deal being brokered between Europe and India could cut off the developing world's supply of cheap medicines. Al Jazeera reports.
Canada’s pharmaceutical industry and the European Union have been quietly lobbying for changes that could give brand-name drugs several years more patent protection here — and potentially add hundreds of millions of dollars to Canadian medication costs annually.
Hundreds of public interest groups across the world have jointly urged prime minister Manmohan Singh not to sign the proposed free trade agreement (FTA) with European Union as the Centre’s role in medicines supply is under threat due to the intellectual property provisions included in the pact.
The EC is seeking a trade agreement with India which will restrict its generic companies from making cheap copycat drugs for poor countries, says MSF, which launches a campaign to oppose this and other allegedly restrictive EC practices today
We are calling for an international week of joint action from 4 October 2010 to 9 October 2010 to call upon the Government of India to reject
the EU-India FTA, especially the provisions relating to intellectual
property rights and investment.
In some countries, up to 90% of children with AIDS are dependent on India's cheap, generic drugs.
We request organizations and individuals across the world to join Delhi Network of Positive People in a sign on letter to issue a appeal to the Indian government to 'not sign on' to any IP provisions in the FTA negotiations.
A new study from UNITAID warns that free trade agreements India is currently negotiating may close the tap on affordable medicines for AIDS patients.
